These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31578802)

  • 1. Insights into IL-29: Emerging role in inflammatory autoimmune diseases.
    Wang JM; Huang AF; Xu WD; Su LC
    J Cell Mol Med; 2019 Dec; 23(12):7926-7932. PubMed ID: 31578802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of interleukin-22 in autoimmune diseases.
    Pan HF; Li XP; Zheng SG; Ye DQ
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):51-7. PubMed ID: 22906768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of IL-35 in inflammatory autoimmune diseases.
    Su LC; Liu XY; Huang AF; Xu WD
    Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic associations in type I interferon related pathways with autoimmunity.
    Delgado-Vega AM; Alarcón-Riquelme ME; Kozyrev SV
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S2. PubMed ID: 20392289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-38: A New Player in Inflammatory Autoimmune Disorders.
    Xie L; Huang Z; Li H; Liu X; Zheng S; Su W
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31387327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into IL-37, the role in autoimmune diseases.
    Xu WD; Zhao Y; Liu Y
    Autoimmun Rev; 2015 Dec; 14(12):1170-5. PubMed ID: 26264940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases.
    Mora-Arias T; Amezcua-Guerra LM
    Arch Immunol Ther Exp (Warsz); 2020 Jan; 68(1):1. PubMed ID: 31915933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor Pathways in Autoimmune Diseases.
    Chen JQ; Szodoray P; Zeher M
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):1-17. PubMed ID: 25687121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting IL-33 in autoimmunity and inflammation.
    Theoharides TC; Petra AI; Taracanova A; Panagiotidou S; Conti P
    J Pharmacol Exp Ther; 2015 Jul; 354(1):24-31. PubMed ID: 25906776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33: a potential therapeutic target in autoimmune diseases.
    Wang S; Ding L; Liu SS; Wang C; Leng RX; Chen GM; Fan YG; Pan HF; Ye DQ
    J Investig Med; 2012 Dec; 60(8):1151-6. PubMed ID: 23076162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
    J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and immunobiology of IL-21 in autoimmunity.
    Long D; Chen Y; Wu H; Zhao M; Lu Q
    J Autoimmun; 2019 May; 99():1-14. PubMed ID: 30773373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Understanding of IL-37 in Human Health and Disease.
    Su Z; Tao X
    Front Immunol; 2021; 12():696605. PubMed ID: 34248996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon lambda in inflammation and autoimmune rheumatic diseases.
    Goel RR; Kotenko SV; Kaplan MJ
    Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferons and autoimmune disorders.
    Meyer O
    Joint Bone Spine; 2009 Oct; 76(5):464-73. PubMed ID: 19773191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IL-17 and IL-22 in autoimmunity and cancer.
    Blake SJ; Teng MW
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
    Leng RX; Pan HF; Tao JH; Ye DQ
    Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.